CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Financial Officer Atabak Mokari sold $9.2M of Corcept Therapeutics Incorporated
Sold$9,177,109
$114.71Price
80,000Shares
−83%Stake
What CORT did after the filing
- The stock from Tue, Aug 4 open, $113.00
- +1.6%
- S&P 500, same days
- +0.3%
Measured over 30 trading days, to the Sep 17 close.
Traded Thu, Jul 30. Filed Mon, Aug 3, 4:30 PM ET, after the close. Returns use the Aug 4 open and the Sep 17 close. Not investment advice.